Ibc Pharmaceuticals Private Limited
About Ibc Pharmaceuticals Private Limited
Data last updated:
Ibc Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India, recognised as a startup by DPIIT. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 05 April 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2011PTC215791. Its GSTIN is 27AACCI5767R1ZP (Maharashtra). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹11 Lakh and a paid-up capital of ₹4.48 Lakh. It is led by directors including Deepak Virbhadra Kabbur and Kranthikiran Siddappa.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹94 Lakh, a growth of 37% compared to the previous year. For the same year it recorded a net profit of ₹16,042 (net margin 0.2%) and EBITDA of ₹10.48 Lakh (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 112% over three years and 20% over five years.
As per MCA filings, the company has open charges of ₹2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No 705 And 706 Arihant Aura, Plot No.13/1 Ttc Industrial Area Turbhe, Thane, Maharashtra, India – 400705
- IndustryChemicals and Materials, Specialty Chemicals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ibc Pharmaceuticals Private Limited
The main business activity of Ibc Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ibc Pharmaceuticals Private Limited FY 2025 filings available
Ibc Pharmaceuticals Private Limited reported revenue of ₹94 Lakh (up 37% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Ibc Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 37% growth in the latest year. EBITDA fell 34% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ibc Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹10.48 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹16,042 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ibc Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ibc Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Ibc Pharmaceuticals Private Limited
Ibc Pharmaceuticals Private Limited is audited by AKASAM & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| AKASAM & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ibc Pharmaceuticals Private Limited
Ibc Pharmaceuticals has 5 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepak Virbhadra Kabbur Also directs: Brio Pharma Technologies Private Limited, Brio Packaging Private Limited, Promedica Pharmaceuticals Private Limited and 1 more | Director | 29 Nov 2017 | 8 Years 10 Months | Current |
| Kranthikiran Siddappa | Director | 29 Nov 2017 | 8 Years 10 Months | Current |
| Ravindranath Tagore Talasila Also directs: Promedica Pharmaceuticals Private Limited | Director | 29 Nov 2017 | 8 Years 10 Months | Current |
| Rajeev Virbhadra Kabbur | Director | 14 Feb 2020 | 6 Years 7 Months | Current |
| Shubham Suresh Mishra Also directs: S2 Genesis LLP, Petals Packtech Private Limited, Brio Engineering Private Limited and 4 more | Director | 05 Apr 2011 | 15 Years 6 Months | Current |
Ownership and Shareholding of Ibc Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ibc Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Nov 2024 | State Bank of India | ₹2 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Ibc Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Ibc Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ibc Pharmaceuticals Private Limited
Ibc Pharmaceuticals Private Limited has 11 board changes on record since 2011: 5 appointments and 6 cessations. The latest: Rajeev Virbhadra Kabbur ceased to be Additional Director on 31 Dec 2020.
3 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Ibc Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ibc Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ibc Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ibc Pharmaceuticals Private Limited
Ibc Pharmaceuticals has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AACCI5767R1ZP | Maharashtra | Active | 01 Jul 2017 |
| 36AACCI5767R2ZP | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ibc Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ibc Pharmaceuticals Private Limited
Ibc Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 05 April 2011 (15+ years old) and is registered under CIN U24239MH2011PTC215791.
Ibc Pharmaceuticals reported revenue of ₹94 Lakh for FY 2025 (up 37% YoY).
Ibc Pharmaceuticals has 5 current directors:
- Deepak Virbhadra Kabbur - Director
- Kranthikiran Siddappa - Director
- Ravindranath Tagore Talasila - Director
- Rajeev Virbhadra Kabbur - Director
- Shubham Suresh Mishra - Director
Ibc Pharmaceuticals reported a net profit of ₹16,042 (net margin 0.2%) and EBITDA of ₹10.48 Lakh (EBITDA margin 11.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ibc Pharmaceuticals is 112% over three years and 20% over five years. In the latest year (FY 2025) revenue rose 37%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ibc Pharmaceuticals is 27AACCI5767R1ZP, registered in Maharashtra. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 36AACCI5767R2ZP (Telangana).
The CIN (Corporate Identification Number) of Ibc Pharmaceuticals is U24239MH2011PTC215791. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ibc Pharmaceuticals was incorporated on 05 April 2011, making it 15+ years old. It is registered with the Registrar of Companies, Mumbai.
Rajeev Virbhadra Kabbur ceased to be Additional Director on 31 Dec 2020. Rajeev Virbhadra Kabbur was appointed as Director on 14 Feb 2020. Deepak Virbhadra Kabbur ceased to be Additional Director on 30 Sep 2019. Ibc Pharmaceuticals has 11 board changes on record in total.
Yes, Ibc Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).